190 results match your criteria: "Department of Neurology and Stroke Centre[Affiliation]"

Ledged Beam Walking Test Automatic Tracker: Artificial intelligence-based functional evaluation in a stroke model.

Comput Biol Med

January 2025

Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Centre, Neurology and Cerebrovascular Disease Group, Neuroscience Area La Paz Institute for Health Research (idiPAZ), (La Paz University Hospital- Universidad Autónoma de Madrid), Spain. Electronic address:

The quantitative evaluation of motor function in experimental stroke models is essential for the preclinical assessment of new therapeutic strategies that can be transferred to clinical research; however, conventional assessment tests are hampered by the evaluator's subjectivity. We present an artificial intelligence-based system for the automatic, accurate, and objective analysis of target parameters evaluated by the ledged beam walking test, which offers higher sensitivity than the current methodology based on manual and visual counting. This system employs a residual deep network model, trained with DeepLabCut (DLC) to extract target paretic hindlimb coordinates, which are categorized to provide a ratio measurement of the animal's neurological deficit.

View Article and Find Full Text PDF

Aim: Successful acute migraine treatment potentially prevents emergency room (ER) consultations but requires that the diagnosis of migraine was given earlier. The aim of this study is to quantify the problem of missed migraine diagnosis prior to ER visits.

Methods: Inclusion criterion for this single-center prospective study was the presentation at the ER for acute headache.

View Article and Find Full Text PDF

Background: Helping people recover from aphasia is among the top 10 research priorities relating to life after stroke.

Objective: We aimed to evaluate the feasibility of dubbing techniques (using newly developed software) for post-stroke aphasia therapy and explore its potential efficacy.

Methods: Randomised, crossover, interventional, feasibility trial that included patients with chronic post-stroke non-fluent aphasia.

View Article and Find Full Text PDF
Article Synopsis
  • Cerebral small vessel disease (SVD) can lead to various cerebrovascular issues, but research on sex differences in SVD is limited.
  • This study analyzed data from over 20,000 patients with acute ischemic stroke to examine whether the presence and severity of cerebral microbleeds (CMB) and other SVD markers differ between males and females.
  • Results showed that males had more frequent CMB while females had fewer lacunes but higher severe white matter hyperintensities, indicating distinct SVD characteristics based on sex.
View Article and Find Full Text PDF

Introduction: Poststroke hyperglycaemia is an independent risk factor for poorer outcomes in patients treated with mechanical thrombectomy (MT) and is associated with a lower probability of functional recovery and higher mortality at 3 months. This study aims to evaluate the association between glucose levels during cerebral reperfusion with MT and functional recovery at 3 months, measured by subcutaneous continuous glucose monitoring (CGM) devices.

Methods: This prospective observational study aims to recruit 100 patients with ischaemic stroke and large anterior circulation vessel occlusion, in whom MT is indicated.

View Article and Find Full Text PDF

Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort Studies.

Neurology

August 2024

From the School of Cardiovascular and Metabolic Health (A.C.C., G. Katsas, J.Y., T.J.Q., R.C., K.D., J.D.), University of Glasgow, United Kingdom; Department of Neurology (Markus Arnold), University Hospital Zurich, Switzerland; Liverpool Centre for Cardiovascular Science (A.H.A.-R.), and Cardiovascular and Metabolic Medicine (A.H.A.-R.), Institute of Life Course and Medical Sciences, University of Liverpool, United Kingdom; Department of Neurology and Stroke Centre (G.M.D.M., M.K.), University Hospital Basel and University of Basel; Department of Neurology (Marcel Arnold), University Hospital Bern; Department of Neurology and Stroke Center (T.K., K.N.), Cantonal Hospital Aarau; Department of Neurology (C.W.C.), Neurocenter (EOC) of Southern Switzerland, Lugano; Department of Neurology (G. Kägi), Cantonal Hospital St. Gallen, Switzerland; Neurology Service (A.B.), Germans Trias i Pujol University Hospital, Barcelona; Neurovascular Research Group (J.M.), Biomedicine Institute of Seville, Spain; Department of Internal Medicine (G.N.), Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece; Department of Neurology (C.F.), Goethe University, Frankfurt am Main, Germany; and Institute of Clinical Chemistry (K.S., A.V.E.), University Hospital of Zurich, Switzerland.

Background And Objectives: Prolonged cardiac monitoring (PCM) increases atrial fibrillation (AF) detection after ischemic stroke, but access is limited, and it is burdensome for patients. Our objective was to assess whether midregional proatrial natriuretic peptide (MR-proANP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) could classify people who are unlikely to have AF after ischemic stroke and allow better targeting of PCM.

Methods: We analyzed people from the Biomarker Signature of Stroke Aetiology (BIOSIGNAL) study with ischemic stroke, no known AF, and ≥3 days cardiac monitoring.

View Article and Find Full Text PDF

Aims: Anticoagulation can prevent stroke and prolong lives in patients with atrial fibrillation (AF). However, anticoagulated patients with AF remain at risk of death. The aim of this study was to investigate the causes of death and factors associated with all-cause and cardiovascular death in the XANTUS population.

View Article and Find Full Text PDF

The impact of experimental diabetes on intracerebral haemorrhage. A preclinical study.

Biomed Pharmacother

July 2024

Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Centre, Neurology and Cerebrovascular Disease Group, Neuroscience Area, Hospital La Paz Institute for Health Research - IdiPAZ (La Paz University Hospital, Universidad Autónoma de Madrid), Madrid, Spain. Electronic address:

Although diabetes mellitus negatively affects post-ischaemic stroke injury and recovery, its impact on intracerebral haemorrhage (ICH) remains uncertain. This study aimed to investigate the effect of experimental diabetes (ED) on ICH-induced injury and neurological impairment. Sprague-Dawley rats were induced with ED 2 weeks before ICH induction.

View Article and Find Full Text PDF

Exonuclease editor promotes precision of gene editing in mammalian cells.

BMC Biol

May 2024

China-New Zealand Joint Laboratory on Biomedicine and Health, CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Centre for Regenerative Medicine and Health, Hong Kong Institute of Science and Innovation, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou Medical University, Guangzhou, 510530, China.

Background: Many efforts have been made to improve the precision of Cas9-mediated gene editing through increasing knock-in efficiency and decreasing byproducts, which proved to be challenging.

Results: Here, we have developed a human exonuclease 1-based genome-editing tool, referred to as exonuclease editor. When compared to Cas9, the exonuclease editor gave rise to increased HDR efficiency, reduced NHEJ repair frequency, and significantly elevated HDR/indel ratio.

View Article and Find Full Text PDF

Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial Feasibility.

Neurology

May 2024

From the Predictive Analytics and Comparative Effectiveness (PACE) Center (A.Y.W., J.N., B.K., D.K., D.M.K.), Institute for Clinical Research and Health Policy Studies (ICRHPS), Tufts Medical Center, Boston, MA; Department of Clinical Neurology (P.M.R., L.L., S.M., L.E.S.), Oxford University, London, United Kingdom; Comprehensive Stroke Center and Department of Neurology (J.L.S.), David Geffen School of Medicine, University of California, Los Angeles; Comprehensive Stroke Center (S.E.K.), Department of Neurology, University of Pennsylvania Medical Center, Philadelphia; Division of Cardiology (J.C.), Department of Medicine, University of Colorado Denver, Aurora; Université Paris Cité (J.-L.M.), Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266; GHU-Paris Psychiatrie et Neurosciences (J.-L.M.), Hôpital Sainte Anne; Département de Physiologie (G.D.), Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil (UPEC); Centre d'Investigations Cliniques (G.C.), Unité de Recherche Clinique, Hôpital Européen Georges-Pompidou, Assistance Publique-Hôpitaux de Paris, France; Department of Neurology (A.J.F.), Case Western Reserve University, Cleveland, OH; Division of Cardiovascular Medicine (H.C.H., B.L.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Department of Population Health (P.J.), University of Oxford, United Kingdom; Department of Neurology (J.S.K.), Gangneung Asan Hospital, University of Ulsan College of Medicine; Department of Cardiology (P.H.L.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (H.P.M.), Bern University Hospital; Medical Faculty (B.M.), University of Bern, Switzerland; Cardiology Department (M.R.), Weill Cornell Medical Center, Cornell, NY; Division of Cardiology (R.W.S.), Department of Medicine, UTHealth/McGovern Medical School and The Memorial Hermann Heart and Vascular Institute, Houston, TX; Department of Cardiology (L.S.), Rigshospitalet, Copenhagen University Hospital, Denmark; Division of Cardiology (J.-K.S.), Asan Medical Center Heart Institute, University of Ulsan College of Medicine, Seoul, South Korea; BHF Cardiovascular Epidemiology Unit (E.D.A.), Department of Public Health and Primary Care, University of Cambridge; Victor Phillip Dahdaleh Heart and Lung Research Institute (E.D.A.), BHF Centre of Research Excellence, School of Clinical Medicine, Addenbrooke's Hospital; NIHR Blood and Transplant Research Unit in Donor Health and Behaviour (E.D.A.), all University of Cambridge; Health Data Research UK Cambridge (E.D.A.), Wellcome Genome Campus and University of Cambridge, Hinxton; University of Cambridge (E.D.A.), United Kingdom; Health Data Science Centre (E.D.A.), Human Technopole, Milan, Italy; Department of Medicine (M.D., S.H.), Columbia University, College of Physicians and Surgeons, New York, NY; Department of Neurology (M.S.V.E.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY; Division of Neurology-Stroke Program (C.J.), Department of Medicine, University Health Network, Toronto Western Hospital, Ontario, Canada; Stroke Center (P.M.), Neurology Service, Lausanne University Hospital; Department of Neurology (M.-L.M., K.N.), University of Bern; Department of Neurology (M.-L.M.), Stadtspital Zürich; Department of Neurology and Stroke Centre (K.N.), Cantonal Hospital Aarau, Switzerland; Sapienza University of Rome (F.P.), Italy; Department of Neurology (J.S.), Hospital Universitari de Girona Dr Josep Trueta - IDIBGI, Spain; Department of Neurology and Stroke Center (C.W.), University Duisburg-Essen, Germany; Department of Public Health (D.K.), Erasmus University Medical Center, Rotterdam, the Netherlands; and Department of Neurology (D.E.T.), Tufts Medical Center/Tufts University School of Medicine, Boston, MA.

Background And Objectives: Whether patent foramen ovale (PFO) closure benefits older patients with PFO and cryptogenic stroke is unknown because randomized controlled trials (RCTs) have predominantly enrolled patients younger than 60 years of age. Our objective was to estimate anticipated effects of PFO closure in older patients to predict the numbers needed to plan an RCT.

Methods: Effectiveness estimates are derived from major observational studies (Risk of Paradoxical Embolism [RoPE] Study and Oxford Vascular Study, together referred to as the "RoPE-Ox" database) and all 6 major RCTs (Systematic, Collaborative, PFO Closure Evaluation [SCOPE] Consortium).

View Article and Find Full Text PDF

Enhancing prime editor flexibility with coiled-coil heterodimers.

Genome Biol

April 2024

China-New Zealand Joint Laboratory On Biomedicine and Health, CAS Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou Medical University, Guangzhou, 510530, China.

Background: Prime editing enables precise base substitutions, insertions, and deletions at targeted sites without the involvement of double-strand DNA breaks or exogenous donor DNA templates. However, the large size of prime editors (PEs) hampers their delivery in vivo via adeno-associated virus (AAV) due to the viral packaging limit. Previously reported split PE versions provide a size reduction, but they require intricate engineering and potentially compromise editing efficiency.

View Article and Find Full Text PDF

Background: Patients with atrial fibrillation (AF) have a high risk for recurrent clinical events after an ischemic stroke. Direct oral anticoagulants (DOAC) are prescribed for secondary prevention. Adherence to DOAC is crucial mainly because of their short elimination half-life.

View Article and Find Full Text PDF

Introduction: A consensus on the management of anticoagulated patients in the acute phase of ischaemic stroke has not yet been established. We aimed to evaluate clinical outcomes in such patients based on the continuation or discontinuation of anticoagulation.

Methods: Retrospective study of patients with acute ischaemic stroke and cardioembolic source receiving anticoagulant therapy is done.

View Article and Find Full Text PDF

Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.

Neurology

April 2024

From the Department of Neurology (L.P.-S., P.C.-R., A.R.-P., A.M.-D., J.M.-F.), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Stroke Research Centre (P.S.N., D.W., D.J.W.), Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology; Department of Statistical Science (G.A., J.G.B.), University College London, United Kingdom; Biomedical Research Institute Sant Pau (M.G.-J., Á.L.-G., G.E.D., D.G.-A.), Barcelona, Spain; UCL Stroke Research Centre (H.D.), Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, United Kingdom; Stroke Research Centre, Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China; Centre for Clinical Brain Sciences (R.A.-S.S.), School of Clinical Sciences, University of Edinburgh, United Kingdom; Neuroradiological Academic Unit (H.R.J.), Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London; Lysholm Department of Neuroradiology, The National Hospital of Neurology and Neurosurgery, Queen Square London; Liverpool Centre for Cardiovascular Science at University of Liverpool (G.Y.L.), Liverpool John Moores University and Liverpool Heart & Chest Hospital, United Kingdom; and Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Denmark; A.A. Martinos Center for Biomedial Imaging (H.A.), Departments of Neurology and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston; Takeda Pharmaceutical Company Limited, Cambridge, MA; Department of Neurology (S.J.), University Hospital Inselspital Bern, University of Bern, Switzerland; Department of Neurology (N.M.B.), Tel-Aviv Sourasky Medical Center; Sackler Faculty of Medicine, Tel-Aviv University, Israel; Department of Neurology (T.G., S.E.); Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Austria; Department of Radiology and Nuclear Medicine (D.H.D.-N.), Erasmus MC, Rotterdam, The Netherlands; Department of Cerebrovascular Medicine (M.K., K.T.), National Cerebral and Cardiovascular Centre, Osaka, Japan; Department of Neurology (F.F.), University Hospital of Würzburg, Germany; Stroke and Ageing Research Group (T.G.P.), School of Clinical Sciences at Monash Health; Peninsula Clinical School (V.K.S.), Peninsula Health, Monash University; National Centre for Healthy Ageing, Melbourne, Australia; Department of Neurology (J.H.H.), Yonsei University College of Medicine, Seoul, South Korea; Department of Neurology (H.-J.B.), Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea; The Neurovascular Research Unit and Health Research Board (P.J.K.), Stroke Clinical Trials Network Ireland, University College Dublin; Department of Neurosurgery (T.I.), Kushiro City General Hospital, Kushiro, Japan; Department of Neurology (J.S., S.K.), Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, The Netherlands; Department of Neurology (Y.Y.), Kansai Medical University, Osaka, Japan; Department of Neurology (D.N.O.), Istanbul Arel University, Turkey; Calgary Stroke Program (E.E.S.), Department of Clinical Neurosciences, Radiology and Community Health Sciences, Hotchkiss Brain Institute, University of Calgary; Centre for Clinical Brain Sciences (J.M.W., F.M.C.), Edinburgh Imaging; and UK Dementia Institute at the University of Edinburgh; Centre for Rural Health (S.D.M.), University of Aberdeen, United Kingdom; Department of Neurology (J.-L.M., D.C.), GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266; Univ. Lille (R.B.), Inserm, CHU de Lille. Lille Neuroscience & Cognition, Lille, France; Memory Aging and Cognition Centre (C.P.C.), Yong Loo Lin School of Medicine, National University of Singapore,; Department of Brain Sciences (R.V.), Imperial College London, United Kingdom; Department of Neurology, Heidelberg University Hospital, Germany; Department of Neurology (N.K.), National Neuroscience Institute, Singapore; Stroke Research Centre (R.J.S.), Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology; Comprehensive Stroke Service, University College London Hospitals NHS Trust, United Kingdom; Department of Neurology (F.-E.D.L.), Donders Institute for Brain, Cognition and Behaviour, Donders Centre for Medical Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Neurology and Stroke Centre (S.T.E.), University Hospital Basel and University of Basel; Neurology and Neurorehabilitation, University Department of Geriatric Medicine FELIX PLATTER; University of Basel, Switzerland; Department of Neurology and Stroke Centre (N.P.), University Hospital Basel and University of Basel; Stroke Center Klinik Hirslanden Zürich, Switzerland; Division of Neurology (Y.O.S.), Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong; Department of Neurology and Stroke Centre (A.Z.), University Hospital Basel and University of Basel, Switzerland; Department of Radiology (J.H.), University Medical Center Utrecht; and Department of Clinical Neurophysiology (W.H.M.), Maastricht University Medical Center/Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands.

Article Synopsis
  • This study looked at whether taking statins, a type of medicine, affects the chances of having a repeat stroke or bleeding in the brain for people who have certain brain issues called cerebral microbleeds (CMBs).
  • They analyzed data from many hospitals and included over 16,000 patients, dividing them into those who took statins and those who didn't.
  • The results showed that people who used statins had a lower risk of having another stroke but didn't show a clear difference in the risk of brain bleeding compared to those who didn't take statins.
View Article and Find Full Text PDF

Background: Although there are numerous treatment methods for NSCLC, long-term survival remains a challenge for patients. The objective of this study is to investigate the role and causal relationship between the target of tetrandrine and non-small cell lung cancer (NSCLC) through transcriptome and single-cell sequencing data, summary-data-based Mendelian Randomization (SMR) and basic experiments. The aim is to provide a new perspective for the treatment of NSCLC.

View Article and Find Full Text PDF

Novel diagnostic biomarkers of oxidative stress, immune- infiltration characteristics and experimental validation of SERPINE1 in colon cancer.

Discov Oncol

November 2023

Department of Metabolic and Bariatric Surgery, the First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510000, Guangdong, China.

Background: Colon cancer (CC) is a prevalent malignant tumor that affects the colon in the gastrointestinal tract. Its aggressive nature, strong invasiveness, and rapid progression make it a significant health concern. In addition, oxidative stress can lead to the production of reactive oxygen species (ROS) that surpass the body's antioxidant defense capacity, causing damage to proteins, lipids, and DNA, potentially promoting tumor development.

View Article and Find Full Text PDF

Glioma remains the most frequent malignancy of the central nervous system. Recently, necroptosis has been identified as a cell death process that mediates the proliferation and development of tumor cells. LncRNAs play a key role in the diagnosis and treatment of various diseases.

View Article and Find Full Text PDF

The prognostic impact of SIGLEC5-induced impairment of CD8 T cell activation in sepsis.

EBioMedicine

November 2023

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Paseo de la Castellana 261, Madrid 28046, Spain; Tumour Immunology Laboratory, IdiPAZ, La Paz University Hospital, Paseo de la Castellana 261, Madrid 28046, Spain; CIBER of Respiratory Diseases (CIBERES), Avenida de Monforte de Lemos, 3-5, Madrid 28029, Spain. Electronic address:

Background: Sepsis is associated with T-cell exhaustion, which significantly reduces patient outcomes. Therefore, targeting of immune checkpoints (ICs) is deemed necessary for effective sepsis management. Here, we evaluated the role of SIGLEC5 as an IC ligand and explored its potential as a biomarker for sepsis.

View Article and Find Full Text PDF

Background: Direct oral anticoagulants (DOAC) effectively prevent recurrent ischaemic events in atrial fibrillation (AF) patients with recent stroke. However, excellent adherence to DOAC is mandatory to guarantee sufficient anticoagulation as the effect quickly subsides.

Aim: To investigate the effect of intake reminders on adherence to DOAC.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is a neurodegenerative condition causing cognitive decline. Oxidative stress (OS) is believed to contribute to neuronal death and dysfunction in AD. We conducted a study to identify differentially expressed OS-related genes (DEOSGs) through bioinformatics analysis and experimental validation, aiming to develop a diagnostic model for AD.

View Article and Find Full Text PDF

This study aimed to investigate the common molecular mechanism between obesity and papillary thyroid cancer (PTC), the most common pathological type of thyroid cancer. In this study, we obtained gene expression datasets for obesity (GSE151839) and PTC (GSE33630) from the Gene Expression Omnibus (GEO). We used the Perl program and R software to identify differentially expressed genes (DEGs) and common genes, perform GO function and KEGG pathway enrichment analysis, construct a protein-protein interaction (PPI) network, identify hub genes, and perform transcription factors (TFs) analysis.

View Article and Find Full Text PDF

Objective: THALES demonstrated that ticagrelor plus aspirin reduced the risk of stroke or death but increased bleeding versus aspirin during the 30 days following a mild-to-moderate acute non-cardioembolic ischaemic stroke (AIS) or high-risk transient ischaemic attack (TIA). There are no cost-effectiveness analyses supporting this combination in Europe. To address this, a cost-effectiveness analysis was performed.

View Article and Find Full Text PDF

To investigate potential diagnostic and prognostic biomarkers associated with prostate cancer (PCa), we obtained gene expression data from six datasets in the Gene Expression Omnibus (GEO) database. The datasets included 127 PCa cases and 52 normal controls. We filtered for differentially expressed genes (DEGs) and identified candidate PCa biomarkers using a least absolute shrinkage and selector operation (LASSO) regression model and support vector machine recursive feature elimination (SVM-RFE) analyses.

View Article and Find Full Text PDF

Changes of migraine aura with advancing age of patients.

J Headache Pain

August 2023

Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, CH-3010, Bern, Switzerland.

Aim: Given the similar presentation of migraine aura and acute ischemic stroke, advancing patient age might change the characteristics of migraine with aura (MA) and be clinically important. Clinical data, however, are limited. Experimental studies indicate a decrease in the magnitude of cortical spreading depression (CSD), the pathophysiological correlate of migraine aura, with advancing age.

View Article and Find Full Text PDF